Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies

The development of cell-, gene- and tissue engineering (CGT)-based therapies must adhere to strict pharmaceutical quality management standards, as for any other biological or small-molecule drug. However, early developments often failed to fully comply with good laboratory practices (GLP) in non-cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Navas, Luis, Torrents, Sílvia, Sánchez-Pernaute, Rosario, Vives, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397649/
https://www.ncbi.nlm.nih.gov/pubmed/35830540
http://dx.doi.org/10.1093/stcltm/szac046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397649/
https://www.ncbi.nlm.nih.gov/pubmed/35830540
http://dx.doi.org/10.1093/stcltm/szac046

Ejemplares similares